Rahul Winayak, Postdoctoral Research Fellow in Kidney Cancer at City of Hope, shared on X:
“Gut microbiome is reshaping precision oncology in mRCC.
City of Hope data at ASCO26 on TOPOSCORE and CBM588 in 1L ICB highlight exciting opportunities as the Ph3 BIOFRONT trial advances. ”
Read also “TRAVERSE: ALLO-316 CAR T-Cell Therapy in Advanced Clear Cell Renal Cell Carcinoma” on OncoDaily.
